Oxytocin, disordered eating, and insulin resistance: a mediation analysis in adults with metabolic dysfunction

Abstract

Aim: Dysregulated eating behavior is closely linked to metabolic dysfunction and may represent a behavioral pathway connecting neuroendocrine signaling to insulin resistance. Oxytocin has emerged as a potential regulator of feeding behavior and food-related reward processing, but the mechanisms linking endogenous oxytocin to metabolic health remain unclear. This study examined whether eating psychopathology mediates the association between circulating oxytocin concentrations and insulin resistance. Methods: In this cross-sectional study, 99 adults with varying metabolic obesity phenotypes completed validated assessments of eating behavior, including emotional eating, external eating, and global eating psychopathology (Eating Disorder Examination Questionnaire, EDE-Q). Plasma oxytocin concentrations and metabolic parameters were measured under standardized conditions. Associations were evaluated using correlation and regression-based mediation analyses with bootstrap estimation (5,000 resamples), adjusted for age and body mass index. Results: Lower oxytocin concentrations were significantly associated with higher eating psychopathology, particularly emotional and external eating. Eating psychopathology was positively associated with insulin resistance (HOMA-IR). Mediation analysis demonstrated a significant indirect association between oxytocin and HOMA-IR through eating psychopathology (ab=−0.181; 95% CI [−0.353, −0.064]), whereas the direct effect was not significant. Similar patterns were observed for emotional and external eating. Because analyses were cross-sectional, the identified mediation pathway represents a statistical indirect association rather than evidence of causality. Conclusions: Lower endogenous oxytocin concentrations were associated with greater eating psychopathology and higher insulin resistance. These findings suggest that behavioral pathways may contribute to the observed association between oxytocin and metabolic dysfunction. However, the cross-sectional design precludes causal inference, and the observed mediation should be interpreted as a statistical association rather than a mechanistically established pathway.

Keywords

oxytocin / eating behavior / insulin resistance / emotional eating / obesity / metabolic health

References

[1] Peterseim CM, Jabbour K, Kamath Mulki A. Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians. Journal of Primary Care Community Health. 2024;15:21501319241309168.

[2] Hamooya BM, Siame L, Muchaili L, Masenga SK, Kirabo A. Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Front Nutr. 2025;12:1661603.

[3] Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, et al. Obesity Pathogenesis: An Endocrine Society Scientific Statement. Endocr Rev. 2017;38:267-96.

[4] Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15:367-78.

[5] Kerem L, Lawson EA. The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans. Int J Mol Sci. 2021;22:7737.

[6] McCormack SE, Blevins JE, Lawson EA. Metabolic Effects of Oxytocin. Endocr Rev. 2020;41:121—45.

[7] Iovino M, Messana T, Marucci S, Triggiani D, Giagulli VA, Guastamacchia E, et al. The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review. Hormones. 2023; 23:15-23.

[8] Thienel M, Fritsche A, Heinrichs M, Peter A, Ewers M, Lehnert H, et al. Oxytocin’s inhibitory effect on food intake is stronger in obese than normal—weight men. Int J Obes. 2016;40:1707—14.

[9] Lawson EA. The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol. 2017;13:700-9.

[10] Leng G, Sabatier N. Oxytocin—The Sweet Hormone? Trends Endocrinol Metab. 2017;28:365-76.

[11] Klement J, Ott V, Rapp K, Brede S, Piccinini F, Cobelli C, et al. Oxytocin Improves β—Cell Responsivity and Glucose Tolerance in Healthy Men. Diabetes. 2016;66:264-71.

[12] Goll N, Moszka N, Kantartzis K, Preissl H, Gruber T, Fritsche L, et al. Oxytocin does not acutely improve glucose tolerance in men with type 2 diabetes. Diabetes Obes Metab. 2024;26:4562—70.

[13] Weingarten MFJ, Scholz M, Wohland T, Horn K, Stumvoll M, Kovacs P, et al. Circulating Oxytocin Is Genetically Determined and Associated With Obesity and Impaired Glucose Tolerance. J Clin Endocrinol Metab. 2019;104:5621—32.

[14] Konttinen H. Emotional eating and obesity in adults: the role of depression, sleep and genes. Proc Nutr Soc. 2020;79:283—9.

[15] Braden A, Ahlich E, Koball AM. Emotional Eating and Obesity: An Update and New Insights. Curr Obes Rep. 2025;14:70.

[16] Chew HSJ, Soong RY, Ang WHD, Ngooi JW, Park J, Yong JQYO, et al. The global prevalence of emotional eating in overweight and obese populations: A systematic review and meta—analysis. Br J Psychol. 2025;116:484-98.

[17] Zare H, Rahimi H, Omidi A, Nematolahi F, Sharifi N. Relationship between emotional eating and nutritional intake in adult women with overweight and obesity: a cross—sectional study. Nutr J. 2024;23:129.

[18] Nolan LJ, Jenkins SM. Food Addiction Is Associated with Irrational Beliefs via Trait Anxiety and Emotional Eating. Nutrients. 2019;11:1711.

[19] Colonnello E, Libotte F, Masi D, Curreli M, Massetti C, Gandini O, et al. Eating behavior patterns, metabolic parameters and circulating oxytocin levels in patients with obesity: an exploratory study. Eat Weight Disord—Stud Anorex Bulim Obes. 2025;30:6.

[20] Anvarova S, Narimova G, Aliyeva A, Khalimova Z, Nasirova K. Plasma oxytocin and leptin in relation to disordered eating: evidence from non—linear modeling across metabolic obesity phenotypes. Front Endocrinol. 2025;16:1693509.

[21] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344-9.

[22] Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al.; AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920—2.

[23] Mond JM, Hay PJ, Rodgers B, Owen C, Beumont PJ. Validity of the Eating Disorder Examination Questionnaire (EDE—Q) in screening for eating disorders in community samples. Behav Res Ther. 2004;42:551-67.

[24] Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression—Based Approach. 3rd ed. New York: Guilford Press; 2022.

[25] MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the Mediation, Confounding and Suppression Effect. Prev Sci. 2000;1:173-81.

[26] Fritz MS, Mackinnon DP. Required Sample Size to Detect the Mediated Effect. Psychol Sci. 2007;18:233—9.

[27] VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E—Value. Ann Intern Med. 2017;167:268-74.